Skip to main content
. 2022 Apr;11(4):835–847. doi: 10.21037/tcr-22-719

Figure 2.

Figure 2

The expression of serum MAPT-AS1 was detected in colorectal cancer patients (A), BC patients (B), ovarian cancer patients (C) and lung cancer patients (D). BC, breast cancer.